Skip to main content
. 2020 Oct 31;17(21):8045. doi: 10.3390/ijerph17218045

Table 2.

Vaccination coverage for HAV and HBV.

Characteristics HAV HBV
Non Vaccinated Vaccinated Complete Schedule Incomplete Schedule Non Vaccinated Vaccinated Complete Schedule Incomplete Schedule
1005 987 18 2 16 479 526 398 128
100% 98.2% 1.8% 11.1% 88.9% 47.7% 52.3% 75.7% 24.3%
SEX Men 937 920 17 1 16 447 490 371 119
93.2% 98.2% 1.8% 5.9% 94.1% 47.7% 52.3% 75.7% 24.3%
Women 68 67 1 1 0 32 36 27 9
6.7% 98.5% 1.5% 100.0% 0.0% 47.1% 52.9% 75.0% 25.0%
AGE <30 years 237 235 2 0 2 125 112 74 38
23.6% 99.2% 0.8% 0.0% 100.0% 52.7% 47.3% 66.1% 33.9%
30–60 years 720 705 15 1 14 332 388 308 80
71.6% 97.9% 2.1% 6.7% 93.3% 46.1% 53.9% 79.4% 20.6%
>60 years 47 46 1 1 0 21 26 16 10
4.6% 97.9% 2.1% 100.0% 0.0% 44.7% 55.3% 61.5% 28.5%
COUNTRY OF ORIGIN Spain 866 850 16 2 14 414 452 342 110
86.2% 98.2% 1.8% 12.5% 87.5% 47.8% 52.2% 75.7% 24.3%
Not Spain 139 137 2 0 2 65 74 56 18
13.8% 98.6% 1.4% 0.0% 100.0% 46.8% 53.2% 75.7% 24.3%

Notes: HAV: hepatitis A, HBV: Hepatitis B.